← Back to Trial

Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer

Trial Locations

• Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Contact: GUONC Research Team · 212-746-1480 · [email protected] (opens in new tab)
• New York Presbyterian/Brooklyn Methodist Hospital Brooklyn, New York, United States
  • Contact: GUONC Research Team · 212-746-1480 · [email protected] (opens in new tab)
• New York Presbyterian/Weill Cornell Medical Center New York, New York, United States
  • Contact: GUOnc Research Team · [email protected] (opens in new tab)
  • Contact: Sarah Yuan · 646-962-6040 · [email protected] (opens in new tab)
• Columbia University Irving Cancer Center New York, New York, United States
  • Contact: Cancer Clinical Trials Research Team · 212-342-5162 · [email protected] (opens in new tab)